z-logo
Premium
Response to treatment in patients with lewis–sumner syndrome
Author(s) -
Attarian Shahram,
Verschueren Annie,
Franques Jérome,
SalortCampana Emmanuelle,
Jouve Elisabeth,
Pouget Jean
Publication year - 2011
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.22024
Subject(s) - polyradiculoneuropathy , medicine , multifocal motor neuropathy , polyneuropathy , chronic inflammatory demyelinating polyneuropathy , surgery , guillain barre syndrome , gastroenterology , antibody , pediatrics , immunology , mismatch negativity , electroencephalography , psychiatry
Our aim was to document the classification of Lewis–Sumner syndrome (L‐SS) based on the response to treatment and the pattern of progression over time. Methods: We retrospectively identified 15 patients with L‐SS treated for at least 12 months. Results: After 1 year, intravenous immunoglobulin was effective in 7 patients, 6 were stable, and 2 worsened. After 5 years, 5 patients had improved, and 3 were stable. These 8 patients needed repeated treatment, and 2 patients gradually worsened. Two patients worsened dramatically after steroid treatment. In 3 patients the neuropathy progressed to the other limbs and developed into an asymmetric polyneuropathy. In 12 other patients the pattern remained multifocal and asymmetric. Conclusions: The possibility of decline resulting from corticosteroids, and the fact that no neurological progression toward a diffuse pattern was observed in the majority of patients suggests that L‐SS is a different entity from chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 2011

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom